Biotechnology
Switzerland
Ireland
Roche
Acquisition
Inflammatory
Diseases
Treatments
M&A Advisory
Lazard
Full Credential Description
Inflazome. Switzerland, Ireland. Announced Date 21/09/2020. Closed Date 18/09/2020. Deal value: $450m. Inflazome Announces Acquisition by Roche. Industry: Inflazome is a biotechnology company focused on developing treatments for inflammatory diseases.